PREMIUM
CARLOS SEGOVIA
Madrid
Updated on Tuesday, 9February2021-22: 57
Share on Facebook
Share on Twitter
Send by email
"The truth is that I like being in a monopoly."
The directors of the pharmaceutical companies that formed a cartel to raise prices for their products used in cancer detection show pleasure in their tight control of the market in the
seized by the
National Markets and Competition Commission
(CNMC).
These are the companies AAA, a subsidiary of Novartis, and Curium, of Luxembourg's Glo controlled in turn by the US fund Capvest.
According to resolution d
Become Premium and
enjoy 3 months for € 1
Take advantage of this limited time offer and access all web content
I want it
Are you already Premium?
Log in
Cancel whenever you want
Check the terms and conditions of the service
According to the criteria of The Trust Project
Know more